aspartic acid has been researched along with Prodromal Characteristics in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moriya, M; Nojo, T; Waragai, M | 1 |
Amato, MP; Bartolozzi, ML; Battaglini, M; De Stefano, N; Gasperini, C; Giorgio, A; Hakiki, B; Malentacchi, G; Portaccio, E; Rossi, F; Santangelo, M; Stromillo, ML | 1 |
Abe, O; Aoki, Y; Gonoi, W; Inoue, H; Iwashiro, N; Kasai, K; Katsura, M; Koike, S; Natsubori, T; Sasaki, H; Takano, Y; Takao, H; Yahata, N; Yamasue, H | 1 |
Amminger, GP; Basu, S; Dietzek, M; Gaser, C; Gussew, A; Lorenz, C; Maitra, R; McGorry, P; Nenadic, I; Reichenbach, JR; Sauer, H; Schönfeld, N; Smesny, S | 1 |
Blennow, K; Hansson, O; Minthon, L; Strandberg, O; Sundgren, PC; Voevodskaya, O; Wahlund, LO; Westman, E; Zetterberg, H | 1 |
5 other study(ies) available for aspartic acid and Prodromal Characteristics
Article | Year |
---|---|
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors | 2017 |
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome.
Topics: Adult; Aspartic Acid; Axons; Brain; Choline; Creatine; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Prodromal Symptoms; Protons; Risk; Syndrome; Young Adult | 2013 |
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Topics: Adolescent; Adult; Aspartic Acid; Chronic Disease; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Risk; Schizophrenia; Young Adult | 2014 |
Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
Topics: Adolescent; Adult; Aspartic Acid; Brain Mapping; Female; Frontal Lobe; Glutamic Acid; Gray Matter; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Risk; Schizophrenia; Young Adult | 2015 |
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloidogenic Proteins; Apolipoprotein E4; Aspartic Acid; Brain; Brain Mapping; Choline; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Positron-Emission Tomography; Prodromal Symptoms; Prospective Studies; Sweden; tau Proteins | 2016 |